CURRENT MEDICATIONS OVERVIEW,,
MEDICATION,GENE(S),PRESCRIBING CONSIDERATIONS BASED ON myDNA TEST
"Aripiprazole (Abilify)",CYP2D6,Major – significant result that may require altering this medication
"Fluoxetine","CYP2C9CYP2D6",Major – significant result that may require altering this medication
"Lisdexamfetamine(Vyvanse)",CYP2D6,"Minor – result should be considered as may affect medicationresponse"
"Melatonin",CYP1A2,Usual prescribing considerations apply
"Olanzapine",CYP1A2,Usual prescribing considerations apply
MEDICATIONS THAT DO NOT HAVE PRESCRIBING CONSIDERATIONS BASED ON myDNA TEST,,
buprenorphine (Norspan),,
MEDICATIONS WITH MAJOR PRESCRIBING CONSIDERATIONS,,,,
DRUG CATEGORY,MEDICATION,"GENE(S)INVOLVED",POTENTIAL CLINICAL ISSUES,"PUBLISHEDGUIDELINES"
"ADHD -miscellaneous agents",Atomoxetine,CYP2D6,Adverse effects,FDA3
Antiarrhythmics,Flecainide,CYP2D6,Adverse effects,DPWG1
"",Propafenone,CYP2D6,Adverse effects,DPWG1
"Anticholinergics(genitourinary)",Tolterodine,CYP2D6,Adverse effects,FDA4
"Antidepressants -other",Vortioxetine,CYP2D6,Adverse effects,"TGA5, FDA6"
MEDICATIONS WITH MAJOR PRESCRIBING CONSIDERATIONS,,,,
DRUG CATEGORY,MEDICATION,"GENE(S)INVOLVED",POTENTIAL CLINICAL ISSUES,"PUBLISHEDGUIDELINES"
"Antidepressants -serotoninnoradrenalinereuptake inhibitors",Venlafaxine,CYP2D6,Adverse effects,DPWG1
"Antidepressants -SSRIs",Fluoxetine,"CYP2D6CYP2C9",Adverse effects,FDA2
"",Fluvoxamine,"CYP2D6CYP1A2",Adverse effects,CPIC7
"",Paroxetine,CYP2D6,Adverse effects,CPIC7
"Antidepressants -tricyclicantidepressants",Amitriptyline,"CYP2D6CYP2C19",Adverse effects,CPIC8
"",Clomipramine,"CYP2D6CYP2C19",Adverse effects,CPIC8
"",Desipramine,CYP2D6,Adverse effects,CPIC8
"",Doxepin,"CYP2D6CYP2C19",Adverse effects,CPIC8
"",Imipramine,"CYP2D6CYP2C19",Adverse effects,CPIC8
"",Nortriptyline,CYP2D6,Adverse effects,CPIC8
Antiemetics,Ondansetron,CYP2D6,"Increased therapeutic and/oradverse effects",CPIC9
Antipsychotics,Aripiprazole,CYP2D6,Adverse effects,"DPWG1,TGA10, FDA11"
"",Brexpiprazole,CYP2D6,Adverse effects,FDA12
"",Haloperidol,CYP2D6,Adverse effects,DPWG
"",Pimozide,CYP2D6,Adverse effects,FDA13
"",Risperidone,CYP2D6,Adverse effects,DPWG1
"",Zuclopenthixol,CYP2D6,Adverse effects,DPWG1
Antitussives,Dextromethorphan,CYP2D6,Adverse effects,-
Beta blockers,Metoprolol,CYP2D6,Adverse effects,DPWG1
"Glaucoma - ocularpreparations",Timolol,CYP2D6,Adverse effects,-
"Immunomodulatorsand antineoplastics",Tamoxifen,CYP2D6,Reduced / inadequate response,CPIC14
Miscellaneous,Eliglustat,CYP2D6,Adverse effects,TGA15
Neurological drugs,Tetrabenazine,CYP2D6,"Increased therapeutic andadverse effects",FDA16
Opioid Analgesics,Codeine,"CYP2D6OPRM1",Reduced / inadequate response,CPIC17
Hydrocodone,CYP2D6,Reduced / inadequate response,,
Tramadol,CYP2D6,Reduced / inadequate response,DPWG1,
MEDICATIONS WITH MINOR PRESCRIBING CONSIDERATIONS,,,,
DRUG CATEGORY,MEDICATION,"GENE(S)INVOLVED",POTENTIAL CLINICAL ISSUES,"PUBLISHEDGUIDELINES"
"Anticholinergics(genitourinary)",Darifenacin,CYP2D6,Adverse effects,-
"",Fesoterodine,CYP2D6,Adverse effects,-
Anticholinesterases,Donepezil,CYP2D6,Adverse effects,-
"",Galantamine,CYP2D6,Adverse effects,-
Anticoagulants,Acenocoumarol,"VKORC1CYP2C9","Increased acenocoumarolsensitivity",
MEDICATIONS WITH MINOR PRESCRIBING CONSIDERATIONS,,,,
DRUG CATEGORY,MEDICATION,"GENE(S)INVOLVED",POTENTIAL CLINICAL ISSUES,"PUBLISHEDGUIDELINES"
"",Warfarin,"VKORC1CYP2C9",Increased warfarin sensitivity,FDA18
"Antidepressants -other",Mirtazapine,"CYP2D6CYP1A2",Adverse effects,-
"Antidepressants -serotoninnoradrenalinereuptake inhibitors",Duloxetine,"CYP2D6CYP1A2",Adverse effects,-
Antiemetics,Metoclopramide,CYP2D6,Adverse effects,-
Antihistamines,Chlorpheniramine,CYP2D6,Adverse effects,-
"",Dexchlorpheniramine,CYP2D6,Adverse effects,-
"",Promethazine,CYP2D6,Adverse effects,-
Antipsychotics,Chlorpromazine,CYP2D6,Adverse effects,-
"",Quetiapine,CYP3A4,Adverse effects,-
Beta blockers,Carvedilol,CYP2D6,Adverse effects,-
"",Nebivolol,CYP2D6,Adverse effects,-
"",Propranolol,"CYP2D6CYP1A2",Adverse effects,-
Miscellaneous,Naltrexone,OPRM1,"Associated with reducedresponse to naltrexone",
Opioid Analgesics,Morphine,OPRM1,"Associated with increasedtherapeutic and/or adverseeffects to morphine",-
"",Oxycodone,CYP2D6,Reduced / inadequate response,DPWG1
"Proton pumpinhibitors",Dexlansoprazole,CYP2C19,Reduced / inadequate response,-
"",Esomeprazole,CYP2C19,Reduced / inadequate response,-
"",Lansoprazole,CYP2C19,Reduced / inadequate response,-
"",Omeprazole,CYP2C19,Reduced / inadequate response,-
"",Pantoprazole,CYP2C19,Reduced / inadequate response,-
"",Rabeprazole,CYP2C19,Reduced / inadequate response,-
Psychostimulants,Dextroamphetamine,CYP2D6,Adverse effects,-
"",Lisdexamfetamine,CYP2D6,Adverse effects,-
Statins,Atorvastatin,"SLCO1B1CYP3A4","Increased therapeutic and/oradverse effects",-
Simvastatin,"SLCO1B1CYP3A4","Increased therapeutic andadverse effects",CPIC19,
MEDICATIONS WITH USUAL PRESCRIBING CONSIDERATIONS,,,,
DRUG CATEGORY,MEDICATION,"GENE(S)INVOLVED",POTENTIAL CLINICAL ISSUES,"PUBLISHEDGUIDELINES"
"Angiotensin receptorblockers",Irbesartan,CYP2C9,"No altered effect predicted bygenotype",-
"",Losartan,CYP2C9,"No altered effect predicted bygenotype",-
"Antidepressants -other",Moclobemide,CYP2C19,"No altered effect predicted bygenotype",-
"Antidepressants -SSRIs",Citalopram,CYP2C19,"No altered effect predicted bygenotype",CPIC7
Escitalopram,CYP2C19,"No altered effect predicted bygenotype",CPIC7,
Sertraline,CYP2C19,"No altered effect predicted bygenotype",CPIC7,
MEDICATIONS WITH USUAL PRESCRIBING CONSIDERATIONS,,,,
DRUG CATEGORY,MEDICATION,"GENE(S)INVOLVED",POTENTIAL CLINICAL ISSUES,"PUBLISHEDGUIDELINES"
Antidiabetics,Gliclazide,"CYP2C9CYP2C19","No altered effect predicted bygenotype",-
"",Glimepiride,CYP2C9,"No altered effect predicted bygenotype",-
"",Glyburide,CYP2C9,"No altered effect predicted bygenotype",-
Antiepileptics,Phenytoin,CYP2C9,"No altered effect predicted bygenotype",CPIC20
Antifungals - Azoles,Voriconazole,CYP2C19,"No altered effect predicted bygenotype",CPIC21
Antiplatelet drugs,Clopidogrel,CYP2C19,"No altered effect predicted bygenotype",CPIC22
Antipsychotics,Clozapine,CYP1A2,"No altered effect predicted bygenotype",-
"",Olanzapine,CYP1A2,"No altered effect predicted bygenotype",-
Benzodiazepines,Clobazam,CYP2C19,"No altered effect predicted bygenotype",-
"",Diazepam,CYP2C19,"No altered effect predicted bygenotype",-
Calcineurin inhibitors,Tacrolimus,CYP3A5,"No altered effect predicted bygenotype",CPIC23
Hypnotics,Melatonin,CYP1A2,"No altered effect predicted bygenotype",-
Miscellaneous,Atazanavir,CYP3A5,"No altered effect predicted bygenotype",-
"",Cyclophosphamide,CYP2C19,"No altered effect predicted bygenotype",-
"",Proguanil,CYP2C19,"No altered effect predicted bygenotype",-
NSAIDs,Celecoxib,CYP2C9,"No altered effect predicted bygenotype",-
"",Diclofenac,CYP2C9,"No altered effect predicted bygenotype",-
"",Flurbiprofen,CYP2C9,"No altered effect predicted bygenotype",-
"",Ibuprofen,CYP2C9,"No altered effect predicted bygenotype",-
"",Indomethacin,CYP2C9,"No altered effect predicted bygenotype",-
"",Mefenamic Acid,CYP2C9,"No altered effect predicted bygenotype",-
"",Meloxicam,CYP2C9,"No altered effect predicted bygenotype",-
"",Piroxicam,CYP2C9,"No altered effect predicted bygenotype",-
Statins,Fluvastatin,"SLCO1B1CYP2C9","No altered effect predicted bygenotype",-
Pravastatin,SLCO1B1,"No altered effect predicted bygenotype",-,
Rosuvastatin,SLCO1B1,"No altered effect predicted bygenotype",-,
